Sentences with phrase «randomized study by»

A randomized study by MDRC found that students in academies were less likely to drop out, had significantly better attendance, and had a 20 percent higher college - application rate than their peers not in academies.

A recent randomized study by Duke University researchers in 2010 involving 144 overweight, unmedicated patients showed that the diet alone could reduce systolic blood pressure (the top blood pressure number) by 11 points and diastolic blood pressure by 7 points.

Not exact matches

For the same reason, it is not easy to prove treatment efficacy by means of controlled, randomized studies, the «gold standard» for evaluating new therapies.

He points to research by a Stanford University researcher, Allan K. Mishra, who has studied PRP for years, whose in his most recent published research includes a large multicenter study [8] involving a host of well - respected orthopedic surgeons around the country who followed 230 patients in a double - blind randomized control study [the gold standard for medical research].

Comparing the Kangaroo care method with standard incubator care, a randomized control study published in the magazine «Annals of Tropical Pediatrics» found that the former is by far superior.

Our study illustrates that a randomized intervention trial with good socioeconomic information can help assess interventions designed to improve population health not only by examining the intervention effects on primary outcomes but also by evaluating the intervention's impact on socioeconomic inequalities.

Regarding the science criticism, it's impossible to scientifically prove by a placebo - controlled, double - blind, randomized study (the gold standard in science) that AP works better than a more distant style of parenting.

We hypothesized that: (a) detection of HR by auscultation or palpation will vary by more than 15 BPM from actual HR; and (b) the inability to accurately determine HR will be associated with errors in management of the neonate during simulated resuscitation.Using a prospective, randomized, controlled study design, 64 subjects participated in three simulated neonatal resuscitation scenarios.

The aim of this study was to evaluate adherence to the Neonatal Resuscitation Program algorithm by subjects working from memory as compared to subjects using a decision support tool that provides auditory and visual prompts to guide implementation of the Neonatal Resuscitation Program algorithm during simulated neonatal resuscitation.Healthcare professionals (physicians, nurse practitioners, obstetrical / neonatal nurses) with a current NRP card were randomized to the control or intervention group and performed three simulated neonatal resuscitations.

To be included in this critical review, studies had to be U.S. - based randomized trials evaluating a breastfeeding promotion intervention, reporting breastfeeding outcome data, enrolling primarily minority participants, and conducting analyses by intention to treat.

By the 1990s, it was recognized that the method by which causality is typically shown in scientific studies — the randomized control trial — had limited application for studying the physical punishment of childreBy the 1990s, it was recognized that the method by which causality is typically shown in scientific studies — the randomized control trial — had limited application for studying the physical punishment of childreby which causality is typically shown in scientific studies — the randomized control trial — had limited application for studying the physical punishment of children.

Group designation was given from a randomisation list, generated using a permuted randomized block design, with permutation block sizes of 3, 6, and 9 units, prior to study initiation by an external statistician.

Participants were randomized using sequentially numbered opaque sealed envelopes, generated by the study's biostatistician.

Most studies attempt to circumvent this by using randomized experimentation, usually comparing reactions, preferences with identical fictional candidates, varying only race / ethnicity / gender.

In three randomized trials, treatment of chronic low back pain with radiofrequency denervation, a procedure that can be performed with different techniques including the application of an electric current to the pain - conducting nerve, resulted in either no improvement or no clinically important improvement in chronic low back pain, according to a study published by JAMA.

«From this we do think it is beneficial, but we would need prospective or randomized studies to determine which groups might not benefit or even be harmed by this therapy.»

The REACT (Randomized Evaluation of an Algorithm for Crohn's Treatment) study, led by Robarts Clinical Trials at Western University (London, Canada) provides valuable new insights for community gastroenterologists which should benefit patients.

Another problem is that modeling studies, like this one, are inherently less powerful than other kinds of medical research: randomized clinical trials, the gold standard in medical research, in which patients are randomly assigned different treatments or no treatment; case - control studies, which compare patients who have a condition with those who do not; or cohort studies, which determine the risk of contracting a disease by studying a group of people with similar demographics.

«Reduce crime and gun violence and stabilize neighborhoods: A randomized controlled study: As much as a 29 percent reduction in gun violence in poor neighborhoods could translate into hundreds of fewer shootings every year for cities affected by blighted spaces.»

What sets the study apart from most previous evaluations is its randomized, controlled design — a relatively new approach honed by lead author Abhijit Banerjee, an economist at the Massachusetts Institute of Technology in Cambridge, and his colleagues.

The new study is a meta - analysis of three randomized controlled trials conducted by the Alliance for Clinical Trials in Oncology (formerly Cancer and Leukemia Group B)(CALGB) with support from the NCI, Intergroupe Francophone du Myélome (IFM), and the Gruppo Italiano Malattie Ematologiche dell «Adulto (GIMEMA).

The determination of each efficacy level was also based on the rigor and quantity of published studies on the drug class: to be in Level A, for example, a class of drugs must have been supported by at least two «Class I» studies — well - designed, double - blind, randomized, placebo - controlled clinical trials.

A randomized phase III trial finding that a new monoclonal antibody, elotuzumab, added to standard therapy, extended the duration of remission for patients with relapsed multiple myeloma by about five months Findings from two phase III studies showing that children with Wilms tumor who have a specific chromosomal abnormality do better with a more intensive, augmented chemotherapy regimen

They were randomized into three treatment groups and received the assigned study drug by injection into the eye until the DME resolved or stabilized.

The new six - year study, «Cognitive enhancement therapy for adult autism spectrum disorder: Results of an 18 - month randomized clinical trial,» involved 54 adults and was led by Shaun Eack, Ph.D., M.S.W., Pitt's David E. Epperson Professor of Social Work and Psychiatry, and Nancy Minshew, M.D., Pitt professor of psychiatry and neurology.

The data safety monitoring board of the trial, as mandated by the study protocol, continues to monitor outcomes in patients with a Recurrence Score of 11 to 25 randomized to chemo - endocrine therapy or endocrine therapy alone.

Motivated by their previous finding of the presence of P - glycoprotein overexpression in the nasal lining of patients with CRS with nasal polyps, the study authors conducted a randomized, double - blind, placebo - controlled clinical trial studying the use of low - dose Verapamil in 18 patients with CRS with nasal polyps.

The findings of the randomized study (S6 - 03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6 - 9, by Dr. Kerin Adelson, assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale - New Haven.

An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial — in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy — showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.

Among recommendations with available information on level of evidence, 90.5 percent of recommendations supported by multiple randomized studies were retained, vs 81.0 percent of recommendations supported by 1 randomized trial or observational data and 73.7 percent of recommendations supported by opinion.

In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutations.

An analysis of more than 600 class I (procedure / treatment should be performed / administered) American College of Cardiology / American Heart Association guideline recommendations published or revised since 1998 finds that about 80 percent were retained at the time of the next guideline revision, and that recommendations not supported by multiple randomized studies were more likely to be downgraded, reversed, or omitted, according to a study in the May 28 issue of JAMA.

A second study, which was another joint effort by UW and UCSF, randomized more than 600 people across the United States assessed as moderately or mildly depressed to one of three interventions: Akili's Project: EVO; iPST, an app deployment of problem - solving therapy; or a placebo control (an app called Health Tips, which offered healthy suggestions).

The first study enrolled older adults diagnosed with late - life depression into a treatment trial where they were randomized to receive either a mobile, tablet - based treatment technology developed by Akili Interactive Labs called Project: EVO or an in - person therapy technique known as problem - solving therapy (PST).

«This is a preliminary study that will hopefully be confirmed by other studies, including a randomized diet intervention study instroke survivors,» she says.

This study was presented at the Featured Clinical Research Session I: Two - year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network The Moderate Ischemic Mitral Regurgitation trial was supported by a cooperative agreement (U01 HL088942) funded by the National Heart Lung and Blood Institute, the National Institutes of Neurological Disorders and Stroke of the National Institutes of Health (NIH), Bethesda, MD, and the Canadian Institutes of Health Research.

In the randomized, controlled, six - week study the scientists measured the impact of zinc on human metabolism by counting DNA strand breaks.

By studying this population over time in a randomized clinical trial, the research team was able to eliminate many confounding variables.

The 10 - year Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three continents.

A 2000 study by Hannah et al. was the largest, randomized controlled trial to examine the type of deliver on mother and infant outcomes.

Thirty - two students were randomized to practice with the 3 - D - printed model or the commercial model in a simulation experience developed by the authors of the study.

The study, called the Minimizing Adverse Hemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX Program (MATRIX), randomized more than 7,200 patients undergoing angioplasty at 78 hospitals in four European countries to bivalirudin or standard coagulation therapy.

This study has been published in the Neuroimage journal and is part of the ActiveBrains project, which is a randomized clinical trial involving more than 100 overweight / obese children led by Francisco B. Ortega.

Inclusion Criteria: • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 • Have histologically or cytologically confirmed advanced or metastatic non-small cell lung cancer (NSCLC)(Stage IIIb or greater) • Measurable disease, as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 • Known PD - L1 tumor status as determined by an immunohistochemistry (IHC) assay performed by the central laboratory on tissue obtained at Screening • A woman of childbearing potential must have a negative highly sensitive serum (beta - human chorionic gonadotropin [beta - hCG]-RRB- at Screening within 14 days prior to study drug administration Inclusion Criteria for Crossover: • Participants must have been randomized to Arm A of the study and had radiographic disease progression according to RECIST 1.1 • Participants must have a mandatory biopsy at the time of disease progression according to RECIST 1.1 prior to crossing over.

This was shown by a randomized study in 23 countries, of more than 1000 melanoma patients, of whom 50 were from the Netherlands Cancer Institute.

Various types of meditation have been shown to improve well - being among different populations such as physicians and the general public.14, 15, 16 Preliminary evidence suggests that meditation - based interventions may slow cellular aging rates by increasing telomerase activity, but many such studies lacked an active control group.17, 18 Recent randomized trials in breast cancer suggest that long - term intensive meditation interventions might have positive effects on telomerase activity.

The randomized, double - blind, placebo - controlled study will evaluate the safety and tolerability of multiple doses of NPT088, as well as pharmacokinetics, immunogenicity and pharmacodynamic characteristics, as measured by Aβ and tau PET imaging.

The results of the study, «Doping in Two Elite Athletics Competitions Assessed by Randomized - Response Surveys» have now been published in the journal Sports Medicine.

Study Selection Randomized placebo - controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected.

«In keeping with a similar randomized clinical trial previously published in the Lancet and conducted by researchers in Rome in collaboration with us here at King's College London, the STAMPEDE study shows that even patients that after 5 years experienced relapse of diabetes after initial and complete remission of the disease continue to maintain excellent control of their blood sugar levels with minimal or no need for glucose lowering drugs.